New Normal Same Cancer
During the pandemic, some of us may have felt uneasy about visiting our medical centres or GPs. In fact, the psychosocial effects of COVID-19 have been a significant factor in the declining numbers of cancer tests as the country dealt with lockdowns and the “new normal” we found ourselves in. Fear of contracting the virus, […]
Petition Pushing To Redress Ovarian Cancer Imbalance
Interview recorded with Radio NZ Listen to the full interview here Cure Our Ovarian Cancer founder Jane Ludemann was diagnosed with a rare form of ovarian cancer in 2017 and was told she would likely live another five to 15 years. She’s spearheading a petition to Parliament asking for the development of ovarian cancer education […]
Ovarian Cancer Petition
Article written by John Lewis for The Star Read the full article here A Dunedin woman with ovarian cancer is calling on legislators and decision-makers to start taking the disease more seriously. Jane Ludemann was diagnosed with low-grade serous carcinoma in 2017, and doctors gave her a life-expectancy of 5-15 years, based on available treatments. […]
Messenger Kept Home, But Message Gets To New York
Article written by Emma Perry and published by the Otago Daily Times. Read the full article here A Dunedin woman was given about $44,000 worth of space on a New York billboard to mark World Ovarian Cancer Day. Jane Ludemann was diagnosed with a rare form of ovarian cancer in 2017, at the age of […]
Advanced Ovarian Cancer Survival Rates Not Improving
Excerpt from report by Associate Professor Peter Sykes Published October 25, 2019 Read the full report here The five-year survival rates for Christchurch women with advanced ovarian cancer haven’t improved in 10 years, according to a study comparing women diagnosed with advanced ovarian cancer between 2000-2001 and 2010-2012. Other developed countries like Australia, USA, Denmark […]
Low-grade serous research at The University of Otago
Dr Kenny Chitcholtan is a senior research fellow at the Department of Obstetrics and Gynaecology of the University of Otago. He is particularly interested in working with 3D ovarian cancer models (specifically organoids), particularly in high-grade serous ovarian cancer. Cure Our Ovarian Cancer received a generous private donation of $75,000 allowing us to fund a […]
Low-Grade Serous Carcinoma Research Grant
Donations through Cure Our Ovarian Cancer have helped fund a research project to study low-grade serous ovarian cancer. The research grant will be administered through the Graci Foundation. Applications for the $35,000 grant will go through an independent review process to determine the best project, and the successful application will be announced in November. Graci […]
Inaugural Low-Grade Serous Ovarian Cancer Symposium
Low-grade serous ovarian cancer is the fourth most common type of ovarian cancer. It disproportionately affects younger women. There is little research, and survival is poor. Cure Our Ovarian Cancer supports women with this cancer on a global level, providing subtype-specific cancer information and fundraising for research to improve their survival. In February 2019, over […]